Nestlé Health Science Invests in Aimmune

News   Nov 07, 2016

 
Nestlé Health Science Invests in Aimmune
 
 
 

RELATED ARTICLES

Existing Diabetes Drug Could Lower Brain Pressure

News

A drug commonly used to treat patients with either obesity or Type II diabetes could be used as a novel new way to lower brain pressure.

READ MORE

Medivir Outsources Compound Management to BioAscent

News

BioAscent is now managing 56,000 samples of Medivir's compound collection for their ongoing drug discovery activities.

READ MORE

Avocado Husks Contain a Plethora of Beneficial Compounds

News

Scientists report that avocado seed husks, which are usually discarded along with the seed, are hidden gold mines packed with a previously unrecognized plethora of chemical compounds.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Diagnostics Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE